Senators Ask For FDA Action On 1,4-Dioxane; EWG Surveying Industry
This article was originally published in The Rose Sheet
Executive Summary
Eliminating any trace of 1,4-dioxane from personal-care products may be an impossibility, but a pair of US senators believe companies should be required to use manufacturing techniques that can minimize the contaminant’s presence. The Environmental Working Group is following up on their citizen petition to FDA by surveying companies whose products may contain the suspected carcinogen in trace amounts.